Market revenue in 2024 | USD 370.8 million |
Market revenue in 2030 | USD 427.0 million |
Growth rate | 2.4% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.64% in 2024. Horizon Databook has segmented the Italy infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing demand for rapid diagnostic procedures and rising prevalence of infectious diseases in the country are driving growth of infectious diseases molecular diagnostics market in Italy. Wide network of manufacturers & distributors in the country are providing essential instruments, kits, & reagents for molecular diagnostics, which is likely to provide a growth platform for this market.
R&D activities are also expected to increase in Italy due to various funds & grants offered for basic research by government & nongovernment organizations. Favorable government initiatives and development of independent diagnostic centers are expected to further boost market growth during the forecast period.
These local market players are receiving EUA for their newly developed molecular tests during the pandemic, which can be utilized by hospital laboratories to obtain quick test results. For instance, in March 2020, DiaSorin Molecular LLC received EUA from the U.S. FDA for Simplexa COVID-19 Direct kit that rapidly detects coronavirus in an hour.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Italy infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account